Navigation Links
Physician Group Opposes FDA's Position on Adult Stem Cells
Date:3/26/2009

The American Stem Cell Therapy Association (ASCTA) is formed in response to the Food and Drug Administration's (FDA) recent position that the adult stem cells found in everyone's body are drugs, a position the ASCTA opposes. This physician organization is establishing laboratory guidelines that will allow doctors to bring adult stem cell therapy to their patients more quickly.

Broomfield, CO (PRWEB) March 26, 2009 -- The American Stem Cell Therapy Association (ASCTA) announced today the online publication of its mission statements and charter. The organization was formed in response to the Food and Drug Administration's (FDA) recent position that the adult stem cells found in everyone's body are drugs, a position the ASCTA opposes. This physician organization is establishing laboratory guidelines that will allow doctors to bring adult stem cell therapy to their patients more quickly. These guidelines will be similar to those used by fertility specialists in In-Vitro Fertilization (IVF) labs, where many of the same cell culture techniques are used.

"Many patients are dying or suffering daily with incurable diseases or problems that require major surgery. These patients should have access to basic adult stem cell therapy now." stated Christopher J. Centeno, M.D, an ASCTA physician member. "ASCTA is establishing guidelines which will allow the safe use of the patient's own adult stem cells under the supervision of doctors." continued Centeno. Another ASCTA physician member, Frank Falco, M.D. stated, "The FDA's position against someone using their own stem cells is taking it too far. We are talking about a person using their own tissue to treat a degenerative disorder or process safely without the use of medications or surgery. Although we agree that oversight and standards are necessary, this should be provided through a physician organization such as ASCTA rather than by a government agency."

Adult stem cells are different than embryonic stem cells. Adult stem cells are found in the patient's body in various tissues. In order to obtain enough stem cells for treatment, they often need to be cultured, similar to today's fertility treatments. Adult stem cells have undergone much more research than embryonic stem cells and therefore are closer to real world treatments. These adult stem cells are taken from the patient's own body (autologous) and ACSTA believes that they are therefore the safest for use in treating patients. "While the Obama administration seems to have opened the embryonic stem cell door, their FDA seems to want to slam the adult stem cell door shut", stated Dr. Centeno.

About the American Stem Cell Therapy Association
The ASCTA is a physician group comprised of various medical and surgical specialties whose goal is to bring safe stem cell therapy to patients by establishing laboratory and clinical guidelines. Christopher J. Centeno, M.D. is a board certified pain management specialist in Colorado who utilizes The Regenexx Procedure, an innovative adult stem cell therapy that helps patients avoid the need for more invasive orthopedic surgery. Dr. Centeno has published numerous medical research papers on the clinical application of adult mesenchymal stem cells. Frank Falco, M.D. is a board certified pain management physician and program director of the Temple University Hospital pain medicine fellowship located in Philadelphia, Pennsylvania who implements minimally invasive techniques for treatment of painful conditions including degenerative spine disorders. For more information, visit http://www.stemcelldocs.org.

Press contact:
Holly Hamann
720-290-0007

###

Read the full story at http://www.prweb.com/releases/ASCTA/stemcelltherapy/prweb2264534.htm.


'/>"/>
Source: PRWeb
Copyright©2009 Vocus, Inc.
All rights reserved  

Related medicine news :

1. TMA Physicians and Legislators: Patients Have a Right to Know
2. AMA Announces Physician Class Action Against WellPoint
3. Physicians Practice and Rose Medical Center Partner to Improve Patient Care in the Denver Metro Area
4. Intensive summer program helps physicians build clinical research careers
5. Manhattan Research: Physician New Media Adoption in Emerging Pharma Markets - Webcast April 3
6. New book chronicles the journeys of women physicians and scientists to fighting cancer
7. Sound Inpatient Physicians Report on New Clinical Processes to Reduce Healthcare Costs and Enhance Care
8. In Texas, Favorable Regulations for Physicians May Backfire in Light of Market Downturn
9. New Book Chronicles the Journeys of Women Physicians and Scientists to the Front Lines of Fighting Cancer
10. Physicians Favor Patient Involvement in Decision Making, But Cite Barriers Such as Time and Money
11. U.S. Rep. Connolly, Inova Health System Physicians, Public Health Groups Call for Congressional Action to Protect Kids from Tobacco
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Physician Group Opposes FDA's Position on Adult Stem Cells
(Date:10/13/2017)... ... ... On The Brink”: the Christian history of the United States and the loss of ... William Nowers. Captain Nowers and his wife, Millie, have six children, ten grandchildren, ... Navy. Following his career as a naval aviator and carrier pilot, he spent ...
(Date:10/12/2017)... ... October 12, 2017 , ... CitiDent and ... apnea using cutting-edge Oventus O2Vent technology. As many as 18 million Americans ... frequent cessation in breathing. Oral appliances can offer significant relief to about 75 ...
(Date:10/12/2017)... Wis. (PRWEB) , ... October 12, 2017 , ... ... standard products to meet the demand of today’s consumer and regulatory authorities worldwide. ... of probiotic experts and tested to meet the highest standard. , These ...
(Date:10/12/2017)... ... October 12, 2017 , ... The American College of Medical ... Friedman, PhD, FACMI, during the Opening Session of AMIA’s Annual Symposium in Washington, D.C. ... honor of Morris F. Collen, a pioneer in the field of medical informatics, this ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about the ... to develop to enable prevention of a major side effect of chemotherapy in ... in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as a ...
Breaking Medicine News(10 mins):
(Date:10/11/2017)... -- Caris Life Sciences ® , a leading innovator in ... medicine, today announced that St. Jude Medical Center,s Crosson ... as its 17 th member. Through participation with ... Institute will help develop standards of care and best ... cancer treatment more precise and effective. ...
(Date:10/10/2017)... Oct. 10, 2017  NDS received FDA 510(k) clearance in May ... battery-powered display stand specifically designed for endoscopy environments. An innovative secondary ... a clinical solution to support the improvement of patient outcomes, procedural ... ... ...
(Date:10/5/2017)... Ill. , Oct. 5, 2017  In ... Association of Oral and Maxillofacial Surgeons (AAOMS) released ... opioids – to be used as a first-line ... pain. Recognizing ... the AAOMS White Paper "Opioid Prescribing: Acute and ...
Breaking Medicine Technology: